Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 EBITDA Up At SEK 7.6 Mln

April 9 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * STRONG CASH FLOW DESPITE THE INFLUENCE OF COVID-19
    * TOTAL NET SALES (INCL. DURABLE GOODS) IN QUARTER AMOUNTED
TO SEK
46.5 (47.7) MILLION
    * Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION
(EBITDA) AMOUNTED TO SEK 7.6 MILLION (3.2)

Source text for Eikon:  ID:nWkr2yHDSL 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xvivo Perfusion AB

See all news